Big Valley, on behalf of Medable

Big Valley, on behalf of Medable


Recent posts by Big Valley, on behalf of Medable

3 min read

Women’s History Month: CEO Michelle Longmire Explores Medable’s Quest for Discovery on “Made by Women” Podcast

By Big Valley, on behalf of Medable on Mar 30, 2021 7:17:39 PM

Women’s History Month has been filled with amazing stories about women’s accomplishments across all walks of life. Unfortunately, women entrepreneurs continue to face an uphill climb. While there are 114% more women entrepreneurs now than 20 years ago, still less than 3 percent of all venture funding goes to women entrepreneurs. That’s especially ironic since private tech companies led by women reportedly achieve 35% higher ROI

Medable founder and CEO Dr. Michelle Longmire recently sat down with Made By Women, a podcast about women who are transforming the world in unique ways. In the conversation with host Kim Azzarelli, Michelle shared her journey to entrepreneurship and how women can support each other’s ventures. 

 

Know Your Strengths & Lean Into Them

Michelle always knew she had a passion for science—inspired in part by her mother (also a scientist)—and was “always inspired by how discovery could transform the world.” 

However, it wasn’t until her time at Stanford that Michelle knew she would be an entrepreneur. While she was working in rare disease research at Stanford, she saw gaps and inefficiencies in how clinical trials were happening. Michelle wanted to use her love of science, rare disease and desire to help patients. She saw that research needed to happen quicker, with less cost and fewer hurdles to trial execution. 

It was that knowledge and empathy for patients that drove her to see how research could be done differently, which led to development of new systems to make clinical trials accessible to nearly everyone and easy to use. 

 

Find Your Way

While less than 3 percent of venture funding goes to women-led startups, Michelle has been able to defy the odds—raising $136 million to date. Michelle attributes the success in part to a good support system and a lot of tenacity.

When Medable began, Michelle was building it on the side. When she wasn’t practicing medicine, she was attending hackathons and learning how to build a startup. She encourages listeners to keep pushing forward, even if they hear no a thousand times. Since it’s harder for women and minorities to get funding, Michelle stressed the importance of leaning on existing support networks for knowledge and potential funding.

Based on Michelle’s vision for clinical trials, along with a couple of talented developers and an initial outside investment of $50,000, she set Medable in motion. She tells listeners: “Starting your own company is freeing. Nothing can prepare you for it, but you’ve just gotta do it.”

 

Support Other Women

Michelle says the tech industry—and every other industry—needs more women entrepreneurs. Part of what will make this possible is through supporting other women. And it can’t be just in good times. When you see another woman entrepreneur struggling, Michelle says you must lift them up. The community is small but strong and growing.

What started out as Michelle’s side hustle and desire to help people with rare diseases, Medable’s decentralized trials platform now has over one million users. 

Michelle leaves listeners with this invaluable advice: “If there’s something you’re passionate about, and you’re thinking about starting your own company, go for it! And before you know it, you’ll have made more progress than you had even originally imagined.”

You can listen to the full podcast episode here, where Michelle shares more about her journey from clinical research to technology CEO. 

 

Topics: clinical trials womens history month
3 min read

Medable Hires Andrea Valente as Chief Operating Officer to Scale Global Delivery of Decentralized Clinical Trials

By Big Valley, on behalf of Medable on Jan 13, 2021 4:22:38 PM

PALO ALTO, Calif. — Jan. 13, 2021 — Medable Inc, the leading cloud platform for patient-centered drug development, today announced the hiring of Andrea Valente as chief operating officer. Valente is a veteran life sciences technology leader who brings deep experience delivering clinical trial technologies to patients at global scale. She has managed operations, product and service delivery for Oracle, IBM, ERT, Siemens and Phase Forward.

 As research and patient care move from the controlled environment of the clinic to the home, focus on operational excellence is paramount. Valente is a proven expert in operationalizing patient technologies in clinical research. She played an early role driving adoption and scale of electronic Clinical Outcome Assessments (eCOAs), one of the first technology categories to interact directly with patients outside of clinical settings. She most recently led development and launch of Oracle’s public health platform to address COVID-19 pandemic response and vaccine trials in the U.S., UK and several developing nations.

 “Andrea is not only an accomplished leader but she has industry-leading experience delivering technologies directly to patients, all over the world. This is very different than delivering solutions into the confines of a clinic,” said Dr. Michelle Longmire, CEO and co-founder of Medable. “Andrea knows what it takes to achieve operational excellence at global scale. She will be an invaluable addition to our leadership team as we continue to execute on our mission to build a highly impactful life sciences technology company.

 Medable experienced record growth in 2020 as the COVID-19 pandemic drove demand for remote clinical trial technologies. By minimizing the need for in-person site visits, Medable customers have achieved unprecedented results – including 3X faster enrollment and over 90 percent retention rates. Medable launched five new products and onboarded more than 50 new clients during the year, growing revenues by more than 400 percent – and fueling $118 million in new funding to accelerate digital and decentralized clinical trial adoption.

 “I’m thrilled to join a leadership team that looks at this space with fresh eyes, while learning from the past – and not necessarily repeating it,” said Valente. “Medable is truly transforming clinical research with a relentless focus on the patient experience and end-to-end process efficiency. We are scaling globally with consulting and implementation services that are grounded in science, clinical research and data analysis – across multiple therapeutic areas.”

 Medable executives are participating in several events at this week’s J.P. Morgan Healthcare Conference, sharing insights, advice and lessons learned from the front lines of decentralized trial adoption. Please click here for more information about Medable’s presence at JPM 2021, or to schedule a meeting with Medable’s executives.

 For ongoing insight about decentralized trial adoption and patient-centered research, follow Medable via our blog, LinkedIn, Twitter and Facebook channels.

About Medable

Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes. Medable is a privately held, venture-backed company headquartered in Palo Alto, California.

# # #

Media Contacts:

Lisa Barbadora, Big Valley Marketing for Medable, +1 (610) 420-3413, media@medable.com

Topics: clinical trials Decentralized Andrea Valente